Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Patent
1993-04-15
1996-12-24
Davenport, Avis M.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
530300, A61K 3800, C07K 500, C07K 700, C07K 1700
Patent
active
055874541
ABSTRACT:
Disclosed are novel omega conotoxin peptides effective in producing analgesia.
REFERENCES:
Basilico, L., et al., "Influence of .omega.-conotoxin on morphine analgesia and withdrawal syndrome in rats," European Journal of Pharmacology 218(1):75-81 (1992).
Basilico, L., et al., "Interaction of Opiates with .omega.-Conotoxin in Guinea Pig Ileum In Vitro," Pharmacological Research 21(1):65 (1989).
Benedek, G., and M. Sziksza, "Potentiation of thermoregulatory and anagesic effects of morphine by calcium antagonists," Pharmacological Research Communications 16(10):1009 (1984).
Ben-Sreti, M. M., et al., "Effects of elevated calcium and calcium antagonists on 6,7-benzomorphan-induced analgesia," European Journal of Pharmacology 90:385-391 (1983).
Carta, F., et al., "Effect of Nifedipine on Morphine-Induced Analgesia," Chemical Abstracts 114(19):abstract No. 178244t.
Contreras, E., et al., "Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance," European Journal of Pharmacology 148:463-466 (1988).
Del Pozo, E., et al., "Analgesic effects of several calcium channel blockers in mice," European Journal of Pharmacology 137:155-160 (1987).
Feldman, D. H., et al., "Omega Conus geographus toxin: a peptide that blocks calcium channels," FEBS Letters 214(2):295-300 (1987).
Hoffmeister, F., and D. Tettenborn, "Calcium agonists and antagonists of the dihydropyridine type: Antinociceptive effects, interference with opiate-.mu.-receptor agonists and neuropharmacological actions in rodents," Psychopharmacology 90:299-307 (1986).
Kavaliers, M., "Stimulatory influences of calcium channel antagonists on stress-induced opioid analgesia and locomotor activity," Brain Research 408:403-407 (1987).
Konno, F., and I. Takayanagi, "Relationship between synaptosomal calcium uptake and antinociceptive action of morphine," Japan. J. Pharmacol. 33:619-626 (1983).
Lux, F., et al., "Interaction of Morphine with Intrathecally Administered Calcium and Calcium Antagonists: Evidence for Supraspinal Endogenous Opioid Mediation of Intrathecal Calcium-Induced Antinociception in Mice," J. Pharmacol. Exp. Therapeutics 246:500 (1988).
Mackie, K., and B. Hille, "Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells," Proc. Natl. Acad. Sci. USA 89:3825-3829 (1992).
Antkiewicz-Michaluk et al., "Role of calcium channels in effects of antidepressant drugs in responsiveness to pain," Chemical Abstracts 115(21):abstract No. 223387a.
Ocana, M., and J. M. Baeyens, "Analgesic effects of centrally administered aminoglycoside antibiotics in mice," Neuroscience Letters 126:67-70 (1991).
Olivera, B. M., et al., "Neuronal Calcium Channel Antagonists. Discrimination between Calcium Channel Subtypes Using .omega.-Conotoxin from Conus Magus venom," Biochemistry 26:2086-2090 (1987).
Prado, W. A., et al., "Antinociception induced by intraperitoneal injection of gentamicin in rats and mice," Pain 41:365-371 (1990).
Welch, S. P., and W. L. Dewey, "A Characterization of the Antinociception Produced by Intracerebroventricular Injection of 8-(N,N-Diethylamino)Octyl-3,4,5,-Trimethoxybenzoate in Mice," J. Pharmacol. Exp. Therapeutics 239:320 (1986).
Woodward, J. J., et al., "Differential sensitivity of synaptosomal calcium entry and endogenous dopamine release to .omega.-conotoxin," Brain Research 475:141-145 (1988).
Knaus, H-G., et al., "Neurotoxic aminoglycoside antibiotics are potent inhibitors [.sup.125 I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes," Naunyn-Schmiedeberg's Arch Pharmacol 336: 583-586 (1987).
Wagner, J. A., et al., "Aminoglycoside effects on voltage-sensitive calcium channels and neurotoxicity," New England J. Medicine 317(26): 1669 (1987).
Gohil Kishor C.
Justice Alan
Miljanich George P.
Singh Tejinder
Valentino Karen L.
Davenport Avis M.
Dehlinger Peter J.
Neurex Corporation
Stratford Carol A.
LandOfFree
Omega conopeptide compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Omega conopeptide compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Omega conopeptide compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1179327